Companies in #Pain

Bresso, Italy-based CNS biopharmaceutical company developing evenamide, a glutamate modulator in Phase 3 for treatment-resistant schizophrenia, and marketing Xadago (safinamide) for Parkinson's disease.

Roswell, GA-based rare disease biotech developing therapies for pain, osteoarthritis, spasticity, and mitochondrial disorders, with a strategic focus on underserved CNS indications.

Discovery-based pharmaceutical company (Shionogi & Co., TYO:4507, Osaka, Japan, founded 1878) with US subsidiary marketing Fetroja (MDR Gram-negative antibiotic), Radicava ORS (ALS), and Xocova (COVID-19 antiviral).